Compare FEMY & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FEMY | ATCX |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | Brazil |
| Employees | N/A | 13 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9M | 21.5M |
| IPO Year | 2021 | N/A |
| Metric | FEMY | ATCX |
|---|---|---|
| Price | $3.87 | $3.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.50 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 1.2M | 21.1K |
| Earning Date | 05-08-2026 | 03-16-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.71 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $2,293,313.00 | N/A |
| Revenue This Year | $105.16 | $827,667.00 |
| Revenue Next Year | $200.23 | $166.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.77 | N/A |
| 52 Week Low | $0.29 | $3.50 |
| 52 Week High | $6.29 | $14.01 |
| Indicator | FEMY | ATCX |
|---|---|---|
| Relative Strength Index (RSI) | 69.85 | 39.78 |
| Support Level | $0.47 | N/A |
| Resistance Level | $6.29 | $5.62 |
| Average True Range (ATR) | 0.41 | 0.37 |
| MACD | 0.18 | 0.01 |
| Stochastic Oscillator | 62.41 | 36.71 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.